Transvaginal Mesh is mainly used for treatment of pelvic organ prolapse and stress urinary incontinence. Recent medical studies confirm that Transvaginal Mesh and Pelvic and Bladder Supports and Bladder Sling products have resulted in serious complications.
An FDA review of scientific literature suggests that many patients who undergo Transvaginal pelvic organ prolapse repair with mesh are exposed to additional risks compared with patients who undergo pelvic organ prolapse repair with stitches alone. Although mesh often corrected anatomy, there was no evidence that mesh provided any greater clinical benefit than nonmesh surgeries.
The study showed that complications include a dangerous, painful condition known as “erosion.” Erosion is a term used to describe a condition where the skin splits and the mesh protrudes.
Other transvaginal mesh complications include:
- Chronic Pain
- Corrective Surgeries
- Painful Intercourse
- Mesh Erosion
A New Jersey jury ruled that Johnson & Johnson Ethicon’s Gynecare Prolift unit failed to properly warn South Dakota nurse Linda Gross of the risks of a vaginal mesh implant and made fraudulent misrepresentations. Jurors awarded Gross a settlement of $3.38 million for lost earnings and past and future medical expenses, plus $7.76 million in punitive damages. After having the device implanted Gross endured 18 operations to fix catastrophic complications. This is the first verdict in more than 2,000 lawsuits filed over the device.